However, therapeutic treatment with Ac2–26, given as a single dose at 24 h post-infection, was not sufficient to decrease MPO, CXCL1, or IL-6 levels in mice compared with untreated WT (BALB/c) animals (Supplementary Figure S4). The gene discussed is CXCL1; the disease is infection.